Ranbaxy To Market Daiichi Sankyo’s Innovative Products In Malaysia – RTT News

Following Singapore, this is the companies’ second marketing synergy in the ASEAN region. Under the arrangement, Ranbaxy will market Cravit (levofloxacin), the synthetic antibacterial agent originally discovered by Daiichi Sankyo, in Malaysia from January …

Leave a Reply

Your email address will not be published.